Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies

This article explores the circumstances under which providers and patients should be able to attempt drugs or combinations for indications for which we still lack formal clinical trials.

Detalles Bibliográficos
Autores principales: Mailankody, Sham, Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016075/
https://www.ncbi.nlm.nih.gov/pubmed/27401893
http://dx.doi.org/10.1634/theoncologist.2016-0086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016075/
https://www.ncbi.nlm.nih.gov/pubmed/27401893
http://dx.doi.org/10.1634/theoncologist.2016-0086

Ejemplares similares